KZIA
Kazia Therapeutics Limited
NASDAQ · Healthcare · Biotechnology · AU
$12.31
+1.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.16x
- Price / sales
- 94.92x
- Price / cash flow
- -11.58x
Enterprise value
- Enterprise value
- $122.5M
- EV / sales
- 67.46x
- EV / EBITDA
- -3.76x
- EV / EBIT
- -3.61x
- Market cap
- $172.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025